Skip to main content

Company
History

Leadership

Clients and Collaborators

By the Numbers
Capabilities
Emmes - CRO

Specialties

Vaccines & Infectious Diseases

Ophthalmology

Clinical Neuroscience

Rare Disease

Cell & Gene Therapy

Government

Additional Specialties

Hematology

Oncology

Maternal & Child Health

Medical Devices

Clinical Services

Biostatistics

Clinical Data Management

Clinical Research Services

Clinical Trial Management

Global Regulatory Affairs

Pharmacovigilance & Medical Monitoring

Veridix - Tech & AI

eClinical Platform

EDC

Decentralized Clinical Trials

Health Navigator

RTSM

eCOA / ePRO

AI Agents

Biostats and Analysis Agent

Data Management Agent

Document Authoring

GlobalTrace

Analytics & Reporting

Clinical Pipelines

VERA
Resources
Newsroom

Blog
Careers
Contact
Contact Us

Locations

Breadcrumb

Emmes Group
News
2025 DIA Global Annual Meeting: Public Sector Sets The Pace For AI In Drug Discovery and Approval

Newsroom

Go back to Newsroom

2025 DIA Global Annual Meeting: Public Sector Sets the Pace for AI in Drug Discovery and Approval

06/17/2025

Article

Go back to Newsroom

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation

Company
Capabilities
- Emmes - CRO
- Veridix - Tech & AI
Resources
- Newsroom
- Blog
Careers
Contact
- Contact Us
- Locations

Copyright ©, The Emmes Company, LLC

Footer

Cookie Policy
External Privacy Notice
FCOI
Emmes EU-U.S. Data Privacy Framework
Purchasing Terms and Conditions
Terms of Use
ISO Certification